Normal view MARC view ISBD view

MicroRNA-142-5p suppresses proliferation and invasion of non-small cell lung cancer cells by targeting programmed cell death receptor ligand 1

By: Gao, Jing.
Contributor(s): Li, S.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2021Edition: Vol.83(4), July-Aug.Description: 742-749p.Subject(s): PHARMACEUTICSOnline resources: Click here In: Indian journal of pharmaceutical sciencesSummary: Lung cancer is one of the most deadly tumor disease in the world and most lung cancer is non-small cell lung cancer. MicroRNAs are considered as a variety of endogenous non-coding RNA, acting as interference during the process after transcription of gene. Recently, microRNA-142-5p, one of the microRNAs, was reported to enhance anti-tumor immune response of non-small cell lung cancer cells by targeting programmed cell death receptor ligand 1. Programmed cell death receptor ligand 1 was also believed to be a regulator of cell proliferation and migration. However, the effect of microRNA-142-5p on proliferation and invasion of non-small cell lung cancer cells via regulating programmed cell death receptor ligand 1 was still unknown. Thus, this study demonstrated that there was low expression level of microRNA-142- 5p in different non-small cell lung cancer cell lines. Programmed cell death receptor ligand 1 was proved to be the target gene of microRNA-142-5p and microRNA-142-5p also had negative correlation with programmed cell death receptor ligand 1. The high expression of microRNA-142-5p lead to suppression of proliferation and invasion in non-small cell lung cancer cells by down regulation of programmed cell death receptor ligand 1. The mechanism of microRNA-142-5p affecting proliferation and invasion of non-small cell lung cancer cells via targeting programmed cell death receptor ligand 1 might give a new thought of tumor therapy.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode Item holds
Articles Abstract Database Articles Abstract Database School of Pharmacy
Archieval Section
Not for loan 2022-0923
Total holds: 0

Lung cancer is one of the most deadly tumor disease in the world and most lung cancer is non-small cell
lung cancer. MicroRNAs are considered as a variety of endogenous non-coding RNA, acting as interference
during the process after transcription of gene. Recently, microRNA-142-5p, one of the microRNAs,
was reported to enhance anti-tumor immune response of non-small cell lung cancer cells by targeting
programmed cell death receptor ligand 1. Programmed cell death receptor ligand 1 was also believed to be
a regulator of cell proliferation and migration. However, the effect of microRNA-142-5p on proliferation
and invasion of non-small cell lung cancer cells via regulating programmed cell death receptor ligand 1
was still unknown. Thus, this study demonstrated that there was low expression level of microRNA-142-
5p in different non-small cell lung cancer cell lines. Programmed cell death receptor ligand 1 was proved
to be the target gene of microRNA-142-5p and microRNA-142-5p also had negative correlation with
programmed cell death receptor ligand 1. The high expression of microRNA-142-5p lead to suppression of
proliferation and invasion in non-small cell lung cancer cells by down regulation of programmed cell death
receptor ligand 1. The mechanism of microRNA-142-5p affecting proliferation and invasion of non-small
cell lung cancer cells via targeting programmed cell death receptor ligand 1 might give a new thought of
tumor therapy.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer

Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha